Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER NANOMEDICINE

Trojan horses for immunotherapy

Nature Nanotechnology volume 14, pages 196–197 (2019)Cite this article

Subjects

Responsive polymersomes enhance the action of STING-targeting cyclic dinucleotides in cancer therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Trojan attack.

References

  1. Adams, D. et al. N. Engl. J. Med. 379, 11–21 (2018).

    Article  CAS  Google Scholar 

  2. Coelho, T. et al. N. Engl. J. Med. 369, 819–829 (2013).

    Article  CAS  Google Scholar 

  3. Shae, D. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-018-0342-5 (2019).

    Article  Google Scholar 

  4. Chen, Q., Sun, L. & Chen, Z. J. Nat. Immunol. 17, 1142–1149 (2016).

    Article  CAS  Google Scholar 

  5. Ablasser, A. et al. Nature 498, 380–384 (2013).

    Article  CAS  Google Scholar 

  6. Corrales, L., McWhirter, S. M., Dubensky, T. W. & Gajewski, T. F. J. Clin. Invest. 126, 2404–2411 (2016).

    Article  Google Scholar 

  7. Woo, S.-R. et al. Immunity 41, 830–842 (2014).

    Article  CAS  Google Scholar 

  8. Corrales, L. et al. Cell Rep. 11, 1018–1030 (2015).

    Article  CAS  Google Scholar 

  9. Fu, J. et al. Sci. Transl. Med. 7, 283ra52 (2015).

    Article  Google Scholar 

  10. Foote, J. B. et al. Cancer Immunol. Res. 5, 468–479 (2017).

    Article  CAS  Google Scholar 

  11. Hanson, M. C. et al. J. Clin. Invest. 125, 2532–2546 (2015).

    Article  Google Scholar 

  12. Koshy, S. T., Cheung, A. S., Gu, L., Graveline, A. R. & Mooney, D. J. Adv. Biosyst. 1, 1600013 (2017).

    Article  Google Scholar 

  13. Manganiello, M. J., Cheng, C., Convertine, A. J., Bryers, J. D. & Stayton, P. S. Biomaterials 33, 2301–2309 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Molecular Engineering, University of Chicago, Chicago, IL, USA

    Jeffrey A. Hubbell & Melody A. Swartz

  2. Ben May Department of Cancer Research, University of Chicago, Chicago, IL, USA

    Melody A. Swartz

Authors
  1. Jeffrey A. Hubbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melody A. Swartz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jeffrey A. Hubbell or Melody A. Swartz.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hubbell, J.A., Swartz, M.A. Trojan horses for immunotherapy. Nat. Nanotechnol. 14, 196–197 (2019). https://doi.org/10.1038/s41565-019-0380-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41565-019-0380-7

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research